Berlin Center for Epidemiology & Health Research, ZEG Berlin

Research institute with focus on pharmacoepidemiology and outcomes research,particularly on drug safety, risk-benefit assessment. Speciality: large multinational de novo Phase-IV studies based on existing networks of physicians/patients as well as newly established networks. Development of study design and all study materials, execution of field work with physicians and patients, data management, analyses, and publication in peer-reviewed journals. Studies mainly with direct patient contact: Cohort studies (registers, active surveillances, physician and patient-based), case-control studies,and cross-sectional surveys in all parts of the world. Full service including advice in crisis management and legal advice.